🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
100 results for “Sandoz”
MedicineActive substanceLicence holderStatus
Aclasta 5 mg solution for infusion
EU/1/05/308/001
Zoledronic acid Sandoz Pharmaceuticals d.d.
Afqlir
EU/1/24/1867/001
Aflibercept Sandoz GmbH
Afqlir
EU/1/24/1867/002
Aflibercept Sandoz GmbH
Aripiprazole Sandoz 10 mg Tablets
EU/1/15/1029/015-028
Aripiprazole Sandoz GmbH
Aripiprazole Sandoz 15 mg Tablets
EU/1/15/1029/029-042
Aripiprazole Sandoz GmbH
Aripiprazole Sandoz 20 mg Tablets
EU/1/15/1029/043-047
Aripiprazole Sandoz GmbH
Aripiprazole Sandoz 30 mg Tablets
EU/1/15/1029/048-061
Aripiprazole Sandoz GmbH
Aripiprazole Sandoz 5 mg Tablets
EU/1/15/1029/001-014
Aripiprazole Sandoz GmbH
ATRIANCE 5mg/ml Solution for Infusion
EU/1/07/403/001
Nelarabine Sandoz Pharmaceuticals d.d.
Binocrit 1 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/410/1-2
Recombinant human erythropoietin alfa Sandoz GmbH
Binocrit 10 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/410/15-16
Recombinant human erythropoietin alfa Sandoz GmbH
Binocrit 2 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/410/3-4
Recombinant human erythropoietin alfa Sandoz GmbH
Binocrit 20 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/410/21-22
Epoetin alfa Sandoz GmbH
Binocrit 3 000 IU/0.3 mL solution for injection in a pre-filled syringe
EU/1/07/410/5-6
Recombinant human erythropoietin alfa Sandoz GmbH
Binocrit 30 000 IU/0.75 mL solution for injection in a pre-filled syringe
EU/1/07/410/23-24
Epoetin alfa Sandoz GmbH
Binocrit 4 000 IU/0.4 mL solution for injection in a pre-filled syringe
EU/1/07/410/7-8
Recombinant human erythropoietin alfa Sandoz GmbH
Binocrit 40 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/410/25-26
Epoetin alfa Sandoz GmbH
Binocrit 5 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/410/9-10
Recombinant human erythropoietin alfa Sandoz GmbH
Binocrit 6 000 IU/0.6 mL solution for injection in a pre-filled syringe
EU/1/07/410/11-12
Recombinant human erythropoietin alfa Sandoz GmbH
Binocrit 8 000 IU/0.8 mL solution for injection in a pre-filled syringe
EU/1/07/410/13-014
Recombinant human erythropoietin alfa Sandoz GmbH
Brinzolamide Sandoz 10mg/ml eye drops, suspension
PA0711/226/001
Brinzolamide Rowex Ltd Marketed
Erelzi 25 mg solution for injection in pre-filled syringe
EU/1/17/1195/001-004
Etanercept Sandoz GmbH
Erelzi 50 mg solution for injection in pre-filled pen
EU/1/17/1195/009-012
Etanercept Sandoz GmbH
Erelzi 50 mg solution for injection in pre-filled syringe
EU/1/17/1195/005-008
Etanercept Sandoz GmbH
Estradot 100 micrograms/24 hours, transdermal patch
PA23311/004/004
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Estradot 25 micrograms/24 hours, transdermal patch
PA23311/004/005
Estradiol Sandoz Pharmaceuticals d.d. Not marketed
Estradot 37.5 micrograms/24 hours, transdermal patch
PA23311/004/001
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Estradot 50 micrograms/24 hours, transdermal patch
PA23311/004/002
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Estradot 75 micrograms/24 hours, transdermal patch
PA23311/004/003
Estradiol Sandoz Pharmaceuticals d.d. Marketed
Fortum 1 g powder for solution for injection or infusion
PA23311/001/002
Ceftazidime Sandoz Pharmaceuticals d.d. Marketed
Fortum 2 g powder for solution for injection or infusion
PA23311/001/003
Ceftazidime Sandoz Pharmaceuticals d.d. Marketed
Fortum 500 mg powder for solution for injection
PA23311/001/001
Ceftazidime Sandoz Pharmaceuticals d.d. Marketed
Hefiya 20 mg solution for injection in pre-filled syringe
EU/1/18/1287/007
Adalimumab Sandoz GmbH
Hefiya 40 mg solution for injection in pre-filled pen
EU/1/18/1287/004-006
Adalimumab Sandoz GmbH
Hefiya 40 mg solution for injection in pre-filled syringe
EU/1/18/1287/001-003
Adalimumab Sandoz GmbH
Hefiya 80 mg solution for injection in pre-filled pen
EU/1/18/1287/010-011
Adalimumab Sandoz GmbH
Hefiya 80 mg solution for injection in pre-filled syringe
EU/1/18/1287/008-009
Adalimumab Sandoz GmbH
Herwenda 150 mg powder for concentrate for solution for infusion
EU/1/23/1762/001
Trastuzumab Sandoz GmbH
HYCAMTIN 0.25 mg hard capsules
EU/1/96/027/006
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
HYCAMTIN 1 mg hard capsules
EU/1/96/027/007
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
Hycamtin 1 mg powder for concentrate for solution for infusion
EU/1/96/027/004
Topotecan (as hydrochloride) Sandoz Pharmaceuticals d.d.
HYCAMTIN 1 mg powder for concentrate for solution for infusion
EU/1/96/027/005
Topotecan (as hydrochloride) Sandoz Pharmaceuticals d.d. Marketed
Hycamtin 4 mg powder for concentrate for solution for infusion
EU/1/96/027/003
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
HYCAMTIN 4 mg powder for concentrate for solution for infusion
EU/1/96/027/001
Topotecan hydrochloride Sandoz Pharmaceuticals d.d.
Hyrimoz 20 mg solution for injection in pre-filled syringe
EU/1/18/1286/007
Adalimumab Sandoz GmbH
Hyrimoz 40 mg solution for injection in pre-filled pen
EU/1/18/1286/004-006
Adalimumab Sandoz GmbH
Hyrimoz 40 mg solution for injection in pre-filled syringe
EU/1/18/1286/001-003
Adalimumab Sandoz GmbH
Hyrimoz 80 mg solution for injection in pre-filled pen
EU/1/18/1286/010-011
Adalimumab Sandoz GmbH
Hyrimoz 80 mg solution for injection in pre-filled syringe
EU/1/18/1286/008-009
Adalimumab Sandoz GmbH
Ibandronic Acid Sandoz 50 mg film-coated tablets
EU/1/11/685/001-005
Ibandronic acid Sandoz GmbH
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.